Mon, Jul 6, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Limmat Capital to become investment manager of large balanced fund mandate

Monday, February 17, 2014
Opalesque Industry Update - With a focus on producing stable long-term returns by investing in bonds, equities, precious metals and alternative investments,LIMMAT CAPITAL Alternative Investments AG has been appointed to manage a large balanced fund mandate starting on February 1. Limmat Capital is an independent FINMA regulated investment management firm in Zurich, Switzerland, specializing in liquid long/short equity and balanced fund strategies.

Launched in 2009, the mandated strategy has assets under management of EUR 196 million, bringing Limmat Capital's total assets under management to CHF 360 million. The mandate's goal is the balancing of long-term returns across market cycles and the preservation of capital under difficult market circumstances. "Compounding matters. By 'compounding' we mean the positive, steady, eventless and therefore boring compounding of capital" said Frederick Barnard, head of research and portfolio manager of the mandate, who has been involved in managing this type of mandate since 1995. Liquidity is of paramount importance in the current financial markets. Therefore the vast majority of the strategy's investments are in liquid instruments.

Last year, Limmat Capital delivered profits to the investors for the ninth consecutive year in its equity flagship strategy, maintaining a strong risk-adjusted return of 13% p.a. with a maximum draw-down of 5.3%, no down year and a lifetime Sharpe Ratio of 2.0 since inception in 2005. Further, the company was approved by the Swiss Financial Market Supervisory Authority (FINMA) as asset manager of foreign collective investment schemes on January 3. The FINMA license marks another important step towards becoming an internationally recognized multi-disciplinary investment management firm and alternative investment platform.

Limmat Capital has evolved from a proprietary trading boutique into a multi-disciplinary investment management firm with a vision to inspire an inventive culture and achieve the full potential and prosperity for clients, employees and partners.

"The long-term interests of our investors are central to how we approach our business and the way we manage our growth. Including this new strategy, our growth revolves around building and expanding our platform in a controlled and intelligent fashion and gaining this new mandate reflects our approach to running business," added Limmat Capital CEO Raphael Rutz, who is also the company's co-founder. "We believe our focus on delivering consistent long-term positive risk-adjusted returns to our investors will also serve the best interests of our business partners and our firm."

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner